Eli Lilly gets CDSCO Panel Nod to Import, Market Antidiabetic Drug Tirzepatide solution for injection Single dose vial Dr. Divya Colin29 Feb 2024 6:00 PM ISTNew Delhi: The drug major Eli Lilly has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Eli Lilly expects to launch diabetes drug Mounjaro in India next year: CEO Ruchika Sharma29 Feb 2024 12:30 PM ISTMounjaro, chemically known as tirzepatide, is currently sold in the UK and Europe under the same brand name for both conditions.
Tirzepatide, novel agent for treating type 2 diabetes has different efficacy in Asians and non-Asians: Study Medha Baranwal27 Feb 2024 1:00 AM ISTChina: A recent meta-analysis published in Diabetes Therapy has shed light on the comparative safety and efficacy of tirzepatide in Asians and...
Weight loss medication tirzepatide may help lower BP in adults with obesity Dr. Kamal Kant Kohli10 Feb 2024 11:15 AM ISTThe new weight loss medication tirzepatide significantly lowered the systolic blood pressure (the top number in a blood pressure reading) for nearly...
Tirzepatide significantly lowers albuminuria across all administered doses in patients with type 2 diabetes: Study Medha Baranwal26 Dec 2023 8:45 AM ISTGreece: Tirzepatide, across all administered doses, probably leads to a significant reduction in albuminuria, while its use is linked with a neutral...
Tirzepatide may reduce CVD Risk in Non-Diabetic Overweight Patients Jacinthlyn Sylvia20 Dec 2023 9:30 PM ISTThe outcomes from the SURMOUNT-1 phase 3 trial found tirzepatide to effectively manage the long-term risk of atherosclerotic cardiovascular disease...
Continued tirzepatide treatment enhances weight loss but discontinuation leads to weight regain: JAMA Dr. Kamal Kant Kohli13 Dec 2023 10:45 AM ISTUSA: Withdrawing tirzepatide may lead to substantial regain of lost weight in obese;/overweight participants, whereas continued treatment augmented...
Eli Lilly Zepbound Injection for Weight Loss gets USFDA okay Roshni Dhar14 Nov 2023 3:54 PM ISTEli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Zepbound (tirzepatide) injection, an...
Tirzepatide significantly reduces predicted risk of ASCVD among patients with obesity without diabetes Niveditha Subramani13 Nov 2023 10:00 AM ISTThe results of the phase 3 trial reveal that tirzepatide treatment over 72 weeks significantly reduced the 10-year predicted risk of ASCVD versus...
Health Bulletin 11/November/2023 Roshni Dhar11 Nov 2023 2:16 PM ISTHere are the top health stories for the day:NBE grants final opportunity for registration to 2021, 2022 batch traineesThe National Board of...
Eli Lilly bags USFDA nod for Zepbound injection for weight loss Ruchika Sharma9 Nov 2023 1:30 PM ISTZepbound should be used with a reduced-calorie diet and increased physical activity.
FDA approves injection Tirzepatide for chronic weight management Dr. Kamal Kant Kohli9 Nov 2023 11:45 AM ISTThe US Food And Drug Administration has approved injection tirzepatide (Zepbound) for weight management in adults on long term basis. Tirzepatide...
